Found: 33
Select item for more details and to access through your institution.
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 9, p. 5763, doi. 10.1007/s10072-022-06154-0
- By:
- Publication type:
- Article
Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 489, doi. 10.1007/s10072-020-04670-5
- By:
- Publication type:
- Article
Effortful speech with distortion of prosody following SARS-CoV-2 infection.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 12, p. 3767, doi. 10.1007/s10072-020-04603-2
- By:
- Publication type:
- Article
OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of headache disorders in the Emergency Department setting.
- Published in:
- Neurological Sciences, 2015, v. 36, n. 7, p. 1153, doi. 10.1007/s10072-015-2148-7
- By:
- Publication type:
- Article
Erratum to: Management of headache disorders in the Emergency Department setting.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Reduction in retinal nerve fiber layer thickness in migraine patients.
- Published in:
- Neurological Sciences, 2013, v. 34, n. 6, p. 841, doi. 10.1007/s10072-012-1103-0
- By:
- Publication type:
- Article
Immigration and neurological diseases: a longitudinal study in an acute neurological care.
- Published in:
- Neurological Sciences, 2012, v. 33, n. 5, p. 979, doi. 10.1007/s10072-011-0868-x
- By:
- Publication type:
- Article
Cerebrovascular risk factors and MRI abnormalities in migraine.
- Published in:
- Neurological Sciences, 2008, v. 29, p. 144, doi. 10.1007/s10072-008-0907-4
- By:
- Publication type:
- Article
Response Predictors in Chronic Migraine: Medication Overuse and Depressive Symptoms Negatively Impact Onabotulinumtoxin-A Treatment.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00678
- By:
- Publication type:
- Article
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01561-w
- By:
- Publication type:
- Article
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01498-6
- By:
- Publication type:
- Article
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.
- Published in:
- European Neurology, 2023, v. 86, n. 2, p. 135, doi. 10.1159/000527674
- By:
- Publication type:
- Article
Functional serotonin 5–HTTLPR polymorphism is a risk factor for migraine with aura.
- Published in:
- Journal of Headache & Pain, 2005, v. 6, n. 4, p. 182, doi. 10.1007/s10194-005-0179-9
- By:
- Publication type:
- Article
Photophobia and migraine outcome during treatment with galcanezumab.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 1, doi. 10.3389/fneur.2022.1088036
- By:
- Publication type:
- Article
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.
- Published in:
- Toxins, 2023, v. 15, n. 12, p. 677, doi. 10.3390/toxins15120677
- By:
- Publication type:
- Article
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5436, doi. 10.1007/s00415-023-11872-2
- By:
- Publication type:
- Article
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 6, p. 2848, doi. 10.1007/s00415-021-10946-3
- By:
- Publication type:
- Article
A follow-up F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis.
- Published in:
- Journal of Neurology, 2014, v. 261, n. 4, p. 663, doi. 10.1007/s00415-013-7228-0
- By:
- Publication type:
- Article
Central nervous system angiitis in Hodgkin's disease.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 4, p. 1, doi. 10.1111/ene.16191
- By:
- Publication type:
- Article
An observational study on monoclonal antibodies against calcitonin‐gene‐related peptide and its receptor.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 6, p. 1764, doi. 10.1111/ene.15761
- By:
- Publication type:
- Article
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 224, doi. 10.1111/ene.15563
- By:
- Publication type:
- Article
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 6, p. 936, doi. 10.1111/head.14123
- By:
- Publication type:
- Article
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01363-y
- By:
- Publication type:
- Article
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01247-1
- By:
- Publication type:
- Article
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.
- Published in:
- Neurology International, 2023, v. 15, n. 1, p. 273, doi. 10.3390/neurolint15010017
- By:
- Publication type:
- Article
Where SUNCT Contacts TN: A Case Report.
- Published in:
- Headache: The Journal of Head & Face Pain, 2013, v. 53, n. 9, p. 1492, doi. 10.1111/head.12007
- By:
- Publication type:
- Article
Endothelial Nitric Oxide Synthase (Glu298Asp) Polymorphism is an Independent Risk Factor for Migraine with Aura.
- Published in:
- Headache: The Journal of Head & Face Pain, 2006, v. 46, n. 10, p. 1575, doi. 10.1111/j.1526-4610.2006.00614.x
- By:
- Publication type:
- Article
Investigating the Association Between Notch3 Polymorphism and Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2006, v. 46, n. 2, p. 317, doi. 10.1111/j.1526-4610.2006.00344.x
- By:
- Publication type:
- Article
A Late 'Migraine': The Only Symptom of an Intrasellar Aneurysm.
- Published in:
- Headache: The Journal of Head & Face Pain, 1997, v. 37, n. 8, p. 527, doi. 10.1046/j.1526-4610.1997.3708527.x
- By:
- Publication type:
- Article
Migraine Stroke: A Possible Complication of Both Migraine With and Without Aura.
- Published in:
- Headache: The Journal of Head & Face Pain, 1996, v. 36, n. 8, p. 481, doi. 10.1046/j.1526-4610.1996.3608481.x
- By:
- Publication type:
- Article